In CP-AKI, ginsenoside Rg3 effectively prevents cisplatin-induced kidney damage by activating the autophagy-mediated inhibition of the NLRP3 pathway, and this process can be blocked by autophagy inhibitor 3-methyladenine (Zhai et al., 2021). The gene discussed is NLRP3; the disease is Nephropathy.